SETBP1 and ETNK1 mutations are more common in aCML versus CNL, even though there are cases of aCML with CSF3R T618I mutations [75]; the presence of this mutation should make the pathologist pause and consider a CNL diagnosis. The gene discussed is SETBP1; the disease is atypical chronic myeloid leukemia, BCR-ABL1 negative.